Provider
P20-21 Removal of Four Medicare Platinum Blue Prior Authorization Requirements — Effective June 1, 2021
Program effective Date: May 03, 2021
Search Results
Displaying 2311 - 2320 of 3770 results
Provider
P28-21 Updated Prior Authorization Requirements for Psychological and Neuropsychological Testing for Commercial and Medicare Advantage Products
Program effective Date: May 03, 2021
Provider
2021 May Bulletins
Program effective Date: May 03, 2021
Provider
QP42-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia Agents
Program effective Date: May 12, 2021
Provider
QP2-21 Update for New to Market Medical Drugs: Aducanumab, Casimersen, Evinacumab, Idecabtagene Vicleucel, and Pegunigalsidase Alfa
Program effective Date: Jan 13, 2021
Provider
2021 June Provider Press
Program effective Date: May 25, 2021
Provider
Inhaled Antibiotics Duplicate Therapy - Commercial - Effective Date 03/01/2025
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2025